Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Explore the intricate relationship between stem cell self-renewal and precancer states to better understand its implications for future cancer therapies
Hematology/Oncology October 9th 2023
ALS News Today
The FDA’s recent concerns about NurOwn’s efficacy and manufacturing consistency could have far-reaching implications for the future of ALS treatment. Stay updated as the agency’s final decision is expected in December.
Neurology October 3rd 2023
Clinical Oncology News
The FDA approval of motixafortide in combination with filgrastim offers a new, evidence-based approach to improve stem cell mobilization in multiple myeloma patients undergoing ASCT.
Hematology/Oncology October 2nd 2023
Pulmonary Fibrosis News
Discover how engineered stem cells could revolutionize the treatment of chronic lung diseases, including pulmonary fibrosis, by offering a more personalized and sustainable approach.
Pulmonology September 13th 2023
Learn how CRISPR-Cas9 gene editing holds the promise of elevating fetal hemoglobin levels and significantly reducing sickle cell disease manifestations. Explore the study’s findings to consider this potential game-changer for your practice.
Hematology September 5th 2023
The American Journal of Sports Medicine
This in-depth research opens up potential avenues for the use of ADMSCs in managing K-L grade 3 knee osteoarthritis, particularly in terms of pain and functional improvements, signifying a promising frontier in osteoarthritis treatment.
Surgery, Orthopedic July 12th 2023